Loading clinical trials...
Loading clinical trials...
Clinical Study on the Combined Detection of Plasma GNB4 and Riplet Gene Methylation for Monitoring Primary Liver Cancer Recurrence
Conditions
Interventions
plasma GNB4 and Riplet genes methylation detection
Locations
1
China
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, China
Start Date
September 2, 2025
Primary Completion Date
June 30, 2027
Completion Date
December 31, 2027
Last Updated
March 23, 2026
NCT06914648
NCT06766643
NCT06430983
NCT04806464
NCT05714124
NCT06325267
Lead Sponsor
Wuhan Ammunition Life-tech Co., Ltd
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions